Yap, T. A., Walton, M. I., Hunter, L. K., Valenti, M., de Haven Brandon, A., Eve, P. D., . . . Garrett, M. D. (2010). Preclinical pharmacology, antitumor activity and development of pharmacodynamic markers for the novel, potent AKT inhibitor CCT128930. Mol Cancer Ther.
Chicago Style citaatYap, Timothy A., et al. "Preclinical Pharmacology, Antitumor Activity and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930." Mol Cancer Ther 2010.
MLA citatieYap, Timothy A., et al. "Preclinical Pharmacology, Antitumor Activity and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930." Mol Cancer Ther 2010.
Let op: Deze citaties zijn niet altijd 100% accuraat.